Clipping of news on Brazilian Culture, Law and Citizenship
08/03/2015
This article was translated by an automatic translation system, and was therefore not reviewed by people.
transparent image
The HIV virus may leave its "hiding" the body with the use of an anticancer drug, researchers.
The main treatment against AIDS today antiretroviral therapy kills the virus in the bloodstream, but leaves these "reservoirs" where the HIV hides intact.
A study published in the scientific publication indicates that an anti-cancer drug is "highly potent" in the reactivation of HIV 'hidden'.
Experts said the findings were interesting, but it's still important to know if it's safe to use the drug in patients.
'Kicking and kill'
A strategy known as 'kick and kill' is considered 'key' for the cure of HIV - the kick would 'wake up' the dormant HIV so the medicine into action and kill the virus.
The staff at the School of Medicine, University of California, Davis, has researched the PEP005 - one of the ingredients in the treatment to prevent cancer - in a skin that has been damaged by the sun.
They tested the drug on cells created in the laboratory and in parts of the immune system taken from 13 people with HIV.
The conclusion was that the "PEP005 is highly potent in reactivation of latent HIV" and that the ingredient is "a new group of important compositions to fight HIV."
One of the researchers, Professor Satya Dandekar, called the discovery a breakthrough.
"We are very excited about the fact that a candidate identified above terms of all standards for the reactivation and eradication of HIV that is already approved and even used by patients. This molecule has a breakthrough potential in traditional clinical studies."
Source: Correio do Estado
Our news are taken in full of our partner sites. For this reason, we can not change their content even in cases of typographical errors.
transparent image
This article was translated by an automatic translation system, and was therefore not reviewed by people.